SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000850529-24-000004
Filing Date
2024-02-05
Accepted
2024-02-05 15:37:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10673
  Complete submission text file 0000850529-24-000004.txt   12628
Mailing Address 5525 NW FISHER CREEK DRIVE CAMAS WA 98607
Business Address 5525 NW FISHER CREEK DRIVE CAMAS WA 98607 650-851-3334
Fisher Asset Management, LLC (Filed by) CIK: 0000850529 (see all company filings)

IRS No.: 202480800 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 0000

Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90214 | Film No.: 24595529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)